Anti-CRIS3/ CRISP3/ Aeg2 functional antibody

Anti-CRIS3/ CRISP3/ Aeg2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CRISP3/CRISP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0822-Ab-1/ GM-Tg-hg-SE0822-Ab-2Anti-Human CRISP3 monoclonal antibodyHuman
GM-Tg-rg-SE0822-Ab-1/ GM-Tg-rg-SE0822-Ab-2Anti-Rat CRISP3 monoclonal antibodyRat
GM-Tg-mg-SE0822-Ab-1/ GM-Tg-mg-SE0822-Ab-2Anti-Mouse CRISP3 monoclonal antibodyMouse
GM-Tg-cynog-SE0822-Ab-1/ GM-Tg-cynog-SE0822-Ab-2Anti-Cynomolgus/ Rhesus macaque CRISP3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0822-Ab-1/ GM-Tg-felg-SE0822-Ab-2Anti-Feline CRISP3 monoclonal antibodyFeline
GM-Tg-cang-SE0822-Ab-1/ GM-Tg-cang-SE0822-Ab-2Anti-Canine CRISP3 monoclonal antibodyCanine
GM-Tg-bovg-SE0822-Ab-1/ GM-Tg-bovg-SE0822-Ab-2Anti-Bovine CRISP3 monoclonal antibodyBovine
GM-Tg-equg-SE0822-Ab-1/ GM-Tg-equg-SE0822-Ab-2Anti-Equine CRISP3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0822-Ab-1/ GM-Tg-hg-SE0822-Ab-2; GM-Tg-rg-SE0822-Ab-1/ GM-Tg-rg-SE0822-Ab-2;
GM-Tg-mg-SE0822-Ab-1/ GM-Tg-mg-SE0822-Ab-2; GM-Tg-cynog-SE0822-Ab-1/ GM-Tg-cynog-SE0822-Ab-2;
GM-Tg-felg-SE0822-Ab-1/ GM-Tg-felg-SE0822-Ab-2; GM-Tg-cang-SE0822-Ab-1/ GM-Tg-cang-SE0822-Ab-2;
GM-Tg-bovg-SE0822-Ab-1/ GM-Tg-bovg-SE0822-Ab-2; GM-Tg-equg-SE0822-Ab-1/ GM-Tg-equg-SE0822-Ab-2
Products NameAnti-CRISP3 monoclonal antibody
Formatmab
Target NameCRISP3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CRISP3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0822-Ag-1Recombinant multi-species CRIS3/ CRISP3/ Aeg2 protein


    Target information

    Target IDGM-SE0822
    Target NameCRISP3
    Gene ID10321,706843
    Gene Symbol and SynonymsAeg2,CRISP-3,CRISP3,CRS3,dJ442L6.3,SGP28
    Uniprot AccessionP54108
    Uniprot Entry NameCRIS3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000096006
    Target ClassificationN/A

    The target: CRISP3, gene name: CRISP3, also named as Aeg2, CRISP-3, CRS3, SGP28, dJ442L6.3. This gene encodes a member of the cysteine-rich secretory protein (CRISP) family within the CRISP, antigen 5 and pathogenesis-related 1 proteins superfamily. The encoded protein has an N-terminal CRISP, antigen 5 and pathogenesis-related 1 proteins domain, a hinge region, and a C-terminal ion channel regulator domain. This protein contains cysteine residues, located in both the N- and C-terminal domains, that form eight disulfide bonds, a distinguishing characteristic of this family. This gene is expressed in the male reproductive tract where it plays a role in sperm function and fertilization, and the female reproductive tract where it plays a role in endometrial receptivity for embryo implantation. This gene is upregulated in certain types of prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.